Dr. Purushothaman Muthukanagaraj, MD

Dr. Muthukanagaraj practices at UHS Binghamton General Hospital in Binghamton, New York, part of United Health Services.

Dr. Muthukanagaraj's NPI, 1083902399, was assigned on July 20, 2011. Dr. Muthukanagaraj holds North Carolina license 2016-01168.

Dr. Muthukanagaraj's primary practice is UHS Binghamton General Hospital, at 10-42 Mitchell Avenue, Binghamton, NY 13903 in Broome County. The practice phone is (607) 763-6000. Dr. Muthukanagaraj also practices at United Health Services Hospitals, 1042 Mitchell Ave, Binghamton, NY 13903.

Dr. Muthukanagaraj's primary practice is UHS Binghamton General Hospital in Binghamton, New York, part of United Health Services. The medical group on file is UHS Wilson Medical Center. Dmand AI also links Dr. Muthukanagaraj to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Muthukanagaraj practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Muthukanagaraj's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Muthukanagaraj is licensed in North Carolina.

CMS data shows 86 Medicare services from Dr. Muthukanagaraj across 2 procedure codes in 2024, for 40 Medicare patients. Medicare paid $6,162 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 40 Medicare patients who saw Dr. Muthukanagaraj in 2024. The largest group is under 65, with 21 patients. 75% of them have anxiety, and 75% have high blood pressure. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Muthukanagaraj's median patient age at 60, with 54% women.

In 2024, Dr. Muthukanagaraj wrote 23 Medicare Part D claims. 87% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $150 in total drug cost. In 2016, CMS named 177 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Muthukanagaraj for performance year 2024, reported as part of a group. Dr. Muthukanagaraj accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Muthukanagaraj, published from 2017 to 2025. 2023 was the busiest year, with 3. Dr. Muthukanagaraj has published most often in Cureus. Dr. Muthukanagaraj's most frequent co-authors are Lauren Nicole Chatham, MD, Zachary Tyler Blom, MD and Anthony Neal Chatham, MD.

CMS Open Payments shows 3 general payments to Dr. Muthukanagaraj from 3 drug and device companies from 2016 to 2022. Consulting fees make up the largest share, 85% of the total. Otsuka Pharmaceutical Development & Commercialization, Inc. paid the most, $175.